Ascending Dose Study of OPC-108459 Intravenous Infusions in Patients With Paroxysmal and Persistent Atrial Fibrillation

NCT01483183 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

40

Enrollment

INDUSTRY

Sponsor class

Stopped Enrollment Difficulty

Conditions

Atrial Fibrillation
Paroxysmal Atrial Fibrillation
Persistent Atrial Fibrillation

Interventions

DRUG: OPC-108459
DRUG: Placebo

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.